ARTICLE
|
doi:10.20944/preprints202011.0385.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Cancer; Immunotherapy; Deconvolution; Alpha diversity; Beta diversity; Precision medicine; Microenvironment; Single-cell RNA sequencing
Online: 13 November 2020 (14:18:40 CET)
REVIEW
|
doi:10.20944/preprints202207.0464.v1
Subject:
Medicine And Pharmacology,
Urology And Nephrology
Keywords:
prostate cancer; six-transmembrane epithelial antigen of the prostate; biomarker; immunotherapy; cancer vaccine; T-cell engaging antibody
Online: 29 July 2022 (14:02:03 CEST)
ARTICLE
|
doi:10.20944/preprints202305.0561.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Nivolumab; immunotherapy; head and neck cancers; HNSCC; chemotherapy; neutrophil to lymphocyt ratio; NLR; second primary malignancy; Cetuximab
Online: 9 May 2023 (04:21:38 CEST)
ARTICLE
|
doi:10.20944/preprints202109.0300.v1
Subject:
Computer Science And Mathematics,
Applied Mathematics
Keywords:
CAR T; Targeted Radionuclide Therapy; TRT; Mathematical Model; Multiple Myeloma; Immunotherapy; Daratumumab; CS1; Combination Therapy
Online: 17 September 2021 (09:32:33 CEST)
ARTICLE
|
doi:10.20944/preprints201908.0131.v1
Subject:
Biology And Life Sciences,
Anatomy And Physiology
Keywords:
pharmacogenomics; immune checkpoint blockade; immunotherapy; drug response prediction; algorithm; mathematical model; precision medicine; personalized medicine
Online: 11 August 2019 (14:51:14 CEST)
REVIEW
|
doi:10.20944/preprints202310.0910.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immune checkpoint inhibitor; resistance mechanism; melanoma; oral mucosal melanoma; immunotherapy; immune checkpoint blockade; anti-PD-1; anti-CTLA-4
Online: 17 October 2023 (03:37:34 CEST)
CASE REPORT
|
doi:10.20944/preprints202408.0349.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Personalized immunotherapy; Precision oncology; Immune checkpoint inhibitor (ICI); Integrative therapies; Adenoid cystic carcinoma (ACC); Frameshift mutation; Splice site mutation
Online: 6 August 2024 (12:39:34 CEST)
ARTICLE
|
doi:10.20944/preprints201909.0324.v1
Subject:
Chemistry And Materials Science,
Nanotechnology
Keywords:
immunotherapy; human hepatoma cells; programmed cell death protein 1 (pd-1); magnetic nanoparticles; peptide-imprinted polymer; natural killer cells
Online: 29 September 2019 (05:28:46 CEST)
ARTICLE
|
doi:10.20944/preprints202110.0145.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immune checkpoint inhibitors; PD-1; PD-L1; CTLA-4; immunotherapy; target therapy; BRAF; MET; melanoma; [18F]FDG PET/CT
Online: 8 October 2021 (14:14:14 CEST)
ARTICLE
|
doi:10.20944/preprints202305.1699.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Vitamin D; mite allergy; dermatophagoides; monomeric allergoid; immunotherapy; rhinitis; anti-histamine; Immunoglobulin; IgE; asthma; corticosteroid; children
Online: 24 May 2023 (05:14:28 CEST)
ARTICLE
|
doi:10.20944/preprints202211.0466.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
γδT, gamma delta T; tumor-infiltrating lymphocytes; TIL; cell therapy; cancer immunotherapy; hyperthermia; modulated electro-hyperthermia
Online: 25 November 2022 (03:15:21 CET)
CASE REPORT
|
doi:10.20944/preprints202005.0220.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
checkpoint inhibitors; tuberculosis; non-small cell lung cancer (NSCLC); Anti-PD-1; toxicity management; immunotherapy; pembrolizumab
Online: 13 May 2020 (04:38:50 CEST)
REVIEW
|
doi:10.20944/preprints202307.1599.v1
Subject:
Biology And Life Sciences,
Biology And Biotechnology
Keywords:
pregnancy associated plasma protein-A; breast cancer; triple negative breast cancer; epithelial-mesenchymal transition; cancer therapy; cancer biomarker; immunotherapy
Online: 24 July 2023 (10:35:57 CEST)
ARTICLE
|
doi:10.20944/preprints202301.0421.v3
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Oncology; Immune Checkpoint Inhibition; PD-1; PD-L1; CTLA-4; Immune Related Adverse Events; Immunotherapy; Tumor Plasticity; Tumor Microenvironment; Optimum Therapy Duration
Online: 6 March 2023 (01:53:16 CET)
REVIEW
|
doi:10.20944/preprints202309.0860.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
gastrointestinal cancer; immunotherapy; cancer vaccines; dendritic cell vaccine; adoptive cell treatment; cytokine-induced killer cells; immune checkpoint inhibitors; angiogenesis inhibition
Online: 13 September 2023 (10:07:21 CEST)
ARTICLE
|
doi:10.20944/preprints202103.0777.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Exosomal PD-L1 mRNA; extracellular vesicles; Triple Negative Breast Cancer; Immunotherapy; PD-L1 axis; Atezolizumab – nab-paclitaxel; Predictive biomarkers; Liquid biopsy
Online: 31 March 2021 (15:27:45 CEST)
REVIEW
|
doi:10.20944/preprints202406.0054.v1
Subject:
Medicine And Pharmacology,
Dermatology
Keywords:
melanoma; cancer vaccine; mRNA vaccine; renin-angiotensin system; drug repurposing; immunotherapy; embryonic stem cells; cancer stem cells
Online: 3 June 2024 (09:54:04 CEST)
REVIEW
|
doi:10.20944/preprints202008.0649.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
antigen processing and presentation; cancer immunotherapy; cross-priming; immunogenicity; major histocompatibility complex; T lymphocyte; tumor-infiltrating lymphocytes, tumor microenvironment; tumor-specific antigen
Online: 30 August 2020 (10:30:50 CEST)
REVIEW
|
doi:10.20944/preprints202305.0122.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Non-small cell lung cancer (NSCLC); EGFR; Tyrosine kinase inhibitors (TKIs); Uncommon mutation; Compound mutation; Intracranial activity; Immunotherapy
Online: 3 May 2023 (09:29:08 CEST)
REVIEW
|
doi:10.20944/preprints202108.0372.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immune checkpoint inhibitors; non-small cell lung carcinoma; PD-1; PD-L1; immune PET; immunotherapy; Radiomics; PET/CT
Online: 18 August 2021 (08:20:43 CEST)
ARTICLE
|
doi:10.20944/preprints202111.0229.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Total metabolic tumor volume; bone marrow to liver ratio; PET/CT; overall survival; immunotherapy; immune checkpoint inhibitor; standardized uptake value; response prediction
Online: 12 November 2021 (14:59:35 CET)
REVIEW
|
doi:10.20944/preprints202112.0525.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
colorectal cancer; immunotherapy; checkpoint blockade; adoptive cell therapy; monoclonal antibodies; oncolytic viruses; anti-cancer vaccines; cytokine; T cell; NK cell
Online: 31 December 2021 (15:14:39 CET)
ARTICLE
|
doi:10.20944/preprints202110.0297.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
gastric cancer; immunotherapy; immune checkpoint blockade (ICB); immune checkpoint inhibitors (ICI),; DNA repair gene signature (DRGS); prognostic biomarker; score system
Online: 20 October 2021 (22:47:19 CEST)
ARTICLE
|
doi:10.20944/preprints201808.0227.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
melanocyte; melanoma; oncology; precision medicine; immunotherapy; pigmentation; vitiligo; albinism; melasma; melanin; dermatology; skin; UV; cancer prevention; IFPCS; PASPCR; SMR; IPCC
Online: 13 August 2018 (11:04:12 CEST)
REVIEW
|
doi:10.20944/preprints202103.0262.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
immune checkpoint inhibitors; immune checkpoint radiolabeled antibodies; PD-1; PD-L1; immune PET; immunotherapy; AI; Radiomics; Deep learning; CAR-T cells
Online: 9 March 2021 (11:12:55 CET)
REVIEW
|
doi:10.20944/preprints202012.0795.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
T cells; chimeric antigen receptor; transgenic T-cell receptor; tumor-infiltrating lymphocytes; exhaustion; terminal differentiation; senescence; apoptosis; adoptive cell transfer; immunotherapy
Online: 31 December 2020 (12:16:55 CET)
REVIEW
|
doi:10.20944/preprints202312.0717.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Cancer immunotherapy 1; Resistance 2; Tumor microenvironment 3; Combination therapies 4; Immune checkpoint targets 5; Adoptive cell therapies 6; Cancer vaccines 7; Personalized medicine 8.
Online: 11 December 2023 (17:53:38 CET)
ARTICLE
|
doi:10.20944/preprints202104.0020.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
hepatitis C virus; hepatocellular carcinoma; immunotherapy; multi-component DNA vaccine; nucleocapsid (core) protein; telomerase reverse transcriptase; eukaryotic expression; CD4+ and CD8+ T cell response; immune suppression; assays of reporter expression; induction of type I interferons
Online: 1 April 2021 (13:18:59 CEST)
REVIEW
|
doi:10.20944/preprints202309.0633.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
metastatic hormone-sensitive prostate cancer; new hormonal agents; transcriptomic profiling; DNA damage repair genes; tumor suppressor genes; androgen receptor; immunotherapy; CDK4/6 inhibitors; PARP inhibitors; AKT inhibitors.
Online: 11 September 2023 (07:17:07 CEST)
REVIEW
|
doi:10.20944/preprints202409.0678.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Malignant Lymphomas; Hodgkin Lymphomas (HL); Non-Hodgkin Lymphomas (NHL); B-cell Neoplasms; T-cell Neoplasms; NK-cell Neoplasms; Grey Zone Lymphomas; Epidemiology; Classification; Staging; Histopathology; Radiotherapy; Chemotherapy; Immunotherapy; Treatment Strategies; Remission; Treatment Complications; Personalized Medicine; Innovative Therapies
Online: 9 September 2024 (11:58:11 CEST)
ARTICLE
|
doi:10.20944/preprints202410.0760.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Immunoglobulins; antibodies; immune response; antibody structure; immunoglobulin function; therapeutic antibodies; immunotherapy; antigen recognition; immune system; B cells; immunoglobulin classification; IgG; IgA; IgM; IgE; IgD; monoclonal antibodies; polyclonal antibodies; antibody engineering; autoimmune diseases; antibody production; immune regulation; immunological memory; antigen-antibody interaction; clinical immunology; molecular immunology; vaccine development; passive immunity; biopharmaceuticals; antibody-mediated immunity; infectious diseases; cancer immunotherapy; inflammation control; immunoglobulin deficiencies; diagnostic antibodies; therapeutic applications in immunology
Online: 10 October 2024 (09:08:58 CEST)